The dopamine receptor D2 antagonist alimemazine, one of the phenothiazines, was previously shown to effectively inhibit the infection of SARS-CoV-2 by interfering with the interaction between the SARS-CoV-2 S protein and neuropilin-1 [33]. This evidence concerns the gene NRP1 and infection.